Data month 2026-08
Alchemab Therapeutics Ltdalchemab.comAI antibody-therapeutics company discovering drugs from disease-resistant individuals.
According to AlphaMoat, in 2026-08 Alchemab Therapeutics (alchemab.com) received 2,476 monthly visits (-46.3% MoM) — ranked #14,660 of 17,407 AI websites with traffic data, and #2,568 of 3,173 in Industry Services; its largest market is UK (100.0% of visits).
Monthly Visits · 2026-08
2.5K-46.3%
Overall Rank (17,407)
#14,660
Industry Services Rank (3,173)
#2,568
Top Market
UK100.0%
What is Alchemab Therapeutics
Product Overview
Alchemab Therapeutics leverages the protective principles of the adaptive immune system, analyzing the antibody repertoires of disease-resistant individuals—such as long-term cancer survivors—to discover and develop a new generation of human-derived therapeutic antibodies.
Key Features4 items
- 01Deep learning with B-cell sequencing
- 02Identify protective antibody responses
- 03Pipeline of neuro and oncology protective therapies
- 04Advance AI-enabled clinical programs
12-Month Traffic Trend
Hover for monthly values
Latest 2.5KMoM-46.3%
2026-06
2.9K
—
2026-07
4.6K
+60.0%
2026-08
2.5K
-46.3%
Visits by Country · Top 5
2026-08 · Share of total visits
UK
2,476100.0%
Popular in Industry Services
Click for details, or "+ Compare" to compare with Alchemab Therapeutics
Data month: 2026-08 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.